Regulation of Alpha 7 Nicotinic Receptor Assembly in Human Smokers
Regulation of Alpha 7 Nicotinic Receptor Assembly in Human Smokers
批准号:
7755428
负责人:
SHERRY LEONARD
金额:
$29.88万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-07-01 至 2011-12-31
关键词:
AffectAllelesAmygdaloid structureAutopsyBindingBiologicalBrainBrain regionBungarotoxinsCell LineCell surfaceCognitionCognitive deficitsCountryDataDiseaseDoctor of PhilosophyDominant-Negative MutationEvaluationEventExonsFamilyGenesGenetic PolymorphismHippocampus (Brain)HumanHuman Cell LineIn VitroIndividualIntronsLengthLinkage DisequilibriumMental disordersMentally Ill PersonsMessenger RNAModelingMolecular ChaperonesMutationNRG1 geneNeuronsNicotineNicotinic ReceptorsNucleus AccumbensOocytesPatientsPeptidesPharmaceutical PreparationsProteinsRNA SplicingReading FramesReceptor GeneRegulationSchizophreniaSensory ProcessSmokeSmokerSmokingSurfaceSystemTestingTobaccoTobacco useTransfectionTranslationsVariantWorkdrug developmentdrug of abusemind controlmutantnon-smokerprematurereceptorreceptor expressiontrafficking
中文摘要
描述(由申请人提供):尼古丁是最常见和最具破坏性的滥用药物之一。尽管在过去的二十年里,这个国家的吸烟率有所下降,但精神疾病患者的吸烟率并没有下降,尤其是精神分裂症患者,其中超过80%的患者吸烟。烟碱受体是与药物的第一个接触点,这使得该受体家族的调控成为重要的第一个研究目标。a7烟碱受体(a7*)与精神疾病精神分裂症的烟草使用和认知和感觉加工缺陷有关。这种受体的基因CHRNA7被选为治疗这种疾病认知缺陷的药物开发中最有希望的靶标。a7*受体的表面表达在精神分裂症患者死后的大脑中较低,但我们在精神分裂症吸烟者的大脑中发现了足够水平的mRNA和蛋白质。这表明,在精神分裂症患者中,受体的组装和运输可能是异常的。本研究将探讨a7*表面受体低水平的两种机制:1)显性负剪接变体的表达,以及2)与a7*组装相关的蛋白RIC3的表达。我们的数据表明,外显子9/内含子9的两个多态性可能与缺失外显子9的剪接变体的存在有关。变异是连锁不平衡的,代表一个突变等位基因。这种多态性与精神分裂症和吸烟有关。剪接变体,缺失外显子9,导致帧改变和过早终止。在卵母细胞模型中,较短的肽在与全长亚基的组装中起显性阴性作用。我们的假设是外显子9/内含子9突变影响RNA剪接和剪接变体缺失外显子9的表达,从而阻碍了胜任受体的组装和表面结合。另一种假说与RIC3的异常表达有关,RIC3是一种促进组装的蛋白质。这项工作的完成将确定假设的机制是否在精神分裂症受试者死后大脑中看到的低水平结合中起作用。Lay声明:烟草制品是最常见和最具破坏性的滥用药物之一,在精神病患者中大量使用。潜在的低水平表面受体可能有助于这些患者吸烟的生物学需求。本研究旨在研究烟草中尼古丁受体细胞表面表达的机制。
英文摘要
DESCRIPTION (provided by applicant): Nicotine is one of the most common and devastating drugs of abuse. Although smoking has declined in this country over the last twenty years, it has not decreased in the mentally ill, particularly in schizophrenia where more than 80% of these patients smoke. Nicotinic receptors are the first point of contact with the drug, making regulation of this receptor family an important first target for study. The a7 nicotinic receptor (a7*) has been implicated in tobacco use and deficits in cognition and sensory processing in the mental illness schizophrenia. The gene for this receptor, CHRNA7, was selected as the most promising target in drug development for cognitive deficits in this disease. Surface expression of the a7* receptor is low in postmortem brain of schizophrenic patients, but we have found adequate levels of both mRNA and protein for the receptor in schizophrenic smokers. This suggests that the assembly and trafficking of the receptor may be aberrant in schizophrenics. This proposal will investigate two mechanisms for the low levels of a7* surface receptors: 1) expression of a dominant negative splice variant, and 2) expression of RIC3, a protein associated with a7* assembly. Our data indicate that two polymorphisms in exon9/intron 9 may be associated with the presence of a splice variant missing exon 9. The variants are in linkage disequilibrium, representing a single mutant allele. The polymorphisms are associated with both schizophrenia and smoking in schizophrenia. The splice variant, missing exon 9, results in a frame change and premature termination. The shorter peptide acts as a dominant negative in assembly with the full-length subunit in an oocyte model. Our hypothesis is that the exon9/intron9 mutation affects RNA splicing and expression of the splice variant missing exon9, which blocks assembly of a competent receptor and surface binding. An alternative hypothesis involves aberrant expression of RIC3, a protein that facilitates assembly. The completion of this work will determine whether the hypothesized mechanisms are operative in the low levels of binding seen in postmortem brain of schizophrenic subjects. Lay statement: Tobacco products are one of the most common and devastating drugs of abuse, and are heavily used in the mentally ill. Underlying low levels of surface receptors may contribute to a biological need for these patients to smoke. This proposal will study mechanisms for cell surface expression of a nicotinic receptor that responds to the nicotine in tobacco.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Expression and Function of the Alpha 7 Nicotinic Receptor in Schizophrenia
-
批准号:8255311
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:SHERRY LEONARD
-
依托单位:
Expression and Function of the Alpha 7 Nicotinic Receptor in Schizophrenia
-
批准号:8398953
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:SHERRY LEONARD
-
依托单位:
Expression and Function of the Alpha 7 Nicotinic Receptor in Schizophrenia
-
批准号:8137492
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:SHERRY LEONARD
-
依托单位:
Regulation of the Human a7 Nicotinic Receptor Gene in Schizophrenia
-
批准号:7871065
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2009
-
负责人:SHERRY LEONARD
-
依托单位:
Regulation of the Human a7 Nicotinic Receptor Gene in Schizophrenia
-
批准号:8063988
-
项目类别:
-
资助金额:$27.44万
-
财政年份:2007
-
负责人:SHERRY LEONARD
-
依托单位:
MOLECULAR BIOLOGY OF NICOTINIC RECEPTORS
-
批准号:7449573
-
项目类别:
-
资助金额:$41.08万
-
财政年份:2007
-
负责人:SHERRY LEONARD
-
依托单位:
Regulation of the Human a7 Nicotinic Receptor Gene in Schizophrenia
-
批准号:7807156
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2007
-
负责人:SHERRY LEONARD
-
依托单位:
Regulation of the Human a7 Nicotinic Receptor Gene in Schizophrenia
-
批准号:7301548
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2007
-
负责人:SHERRY LEONARD
-
依托单位:
Regulation of the Human a7 Nicotinic Receptor Gene in Schizophrenia
-
批准号:7612655
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2007
-
负责人:SHERRY LEONARD
-
依托单位:
MOLECULAR BIOLOGY OF NICOTINIC RECEPTORS
-
批准号:6969112
-
项目类别:
-
资助金额:$48.9万
-
财政年份:2004
-
负责人:SHERRY LEONARD
-
依托单位:
NICOTINIC RECEPTORS AND SMOKING CESSATION
-
批准号:6174839
-
项目类别:
-
资助金额:$12.9万
-
财政年份:1998
-
负责人:SHERRY LEONARD
-
依托单位:
NICOTINIC RECEPTORS AND SMOKING CESSATION
-
批准号:2898307
-
项目类别:
-
资助金额:$12.53万
-
财政年份:1998
-
负责人:SHERRY LEONARD
-
依托单位:
NICOTINIC RECEPTORS AND SMOKING CESSATION
-
批准号:2763946
-
项目类别:
-
资助金额:$12.16万
-
财政年份:1998
-
负责人:SHERRY LEONARD
-
依托单位:
GENETIC DETERMINANTS OF RECEPTOR FUNCTION IN SCHIZOPHRENIA
-
批准号:6111439
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:SHERRY LEONARD
-
依托单位:
GENETIC DETERMINANTS OF RECEPTOR FUNCTION IN SCHIZOPHRENIA
-
批准号:6243057
-
项目类别:
-
资助金额:$21.21万
-
财政年份:1997
-
负责人:SHERRY LEONARD
-
依托单位:
Regulation of Alpha 7 Nicotinic Receptor Assembly in Human Smokers
-
批准号:8013847
-
项目类别:
-
资助金额:$28.99万
-
财政年份:1995
-
负责人:SHERRY LEONARD
-
依托单位:
HUMAN BRAIN NICOTINIC RECEPTORS AND NICOTINE ADDICTION
-
批准号:2122705
-
项目类别:
-
资助金额:$20.0万
-
财政年份:1995
-
负责人:SHERRY LEONARD
-
依托单位:
HUMAN BRAIN NICOTINIC RECEPTORS AND NICOTINE ADDICTION
-
批准号:6126638
-
项目类别:
-
资助金额:$26.39万
-
财政年份:1995
-
负责人:SHERRY LEONARD
-
依托单位:
HUMAN BRAIN NICOTINIC RECEPTORS AND NICOTINE ADDICTION
-
批准号:2122706
-
项目类别:
-
资助金额:$20.73万
-
财政年份:1995
-
负责人:SHERRY LEONARD
-
依托单位:
HUMAN BRAIN NICOTINIC RECEPTORS AND NICOTINE ADDICTION
-
批准号:2733552
-
项目类别:
-
资助金额:$22.42万
-
财政年份:1995
-
负责人:SHERRY LEONARD
-
依托单位:
海外基金